Search Results

STAT5 phosphorylation plus minimal residual disease defines a novel risk classification in adult B‐cell acute lymphoblastic leukaemia.

• Authors : Xu, Xiuli; Huang, Zicong; Ding, Chenhao

Subjects: LYMPHOBLASTIC leukemia; ACUTE leukemia; STAT proteins

• Source: British Journal of Haematology; Aug2024, Vol. 205 Issue 2, p517-528, 12p

Record details

Correction to Bone Marrow Stroma Protects Myeloma Cells From Cytotoxic Damage via Induction of the Oncoprotein MUC1.

Subjects: BONE marrow; STROMAL cells; MULTIPLE myeloma

• Source: British Journal of Haematology; Nov2024, Vol. 205 Issue 5, p2094-2096, 3p

Record details

EBV‐positive HIV‐associated diffuse large B cell lymphomas are characterized by JAK/STAT (STAT3) pathway mutations and unique clinicopathologic features.

• Authors : Chapman, Jennifer R.¹ (AUTHOR); Bouska, Alyssa C.² (AUTHOR); Zhang, Weiwei² (AUTHOR)

Subjects: *STAT proteins; *HIGHLY active antiretroviral therapy; *MUCOSA-associated lymphoid tissue lymphoma

• Source: British Journal of Haematology. Sep2021, Vol. 194 Issue 5, p870-878. 9p.

Record details

An inherited gain‐of‐function risk allele in EPOR predisposes to familial JAK2V617F myeloproliferative neoplasms.

• Authors : Rabadan Moraes, Graciela; Pasquier, Florence; Marzac, Christophe

Subjects: MYELOPROLIFERATIVE neoplasms; ALLELES; CELL lines

• Source: British Journal of Haematology; Jul2022, Vol. 198 Issue 1, p131-136, 6p

Record details

Histopathological features and their prognostic impact in nodular lymphocyte-predominant Hodgkin lymphoma - a matched pair analysis from the German Hodgkin Study Group (GHSG).

• Authors : Hartmann, Sylvia¹; Eichenauer, Dennis A.^2,3; Plütschow, Annette^2,3

Subjects: *HODGKIN'S disease; *STAT proteins; *HISTOPATHOLOGYGERMANY

• Source: British Journal of Haematology. Oct2014, Vol. 167 Issue 2, p238-242. 5p.

Record details

Management of polycythaemia vera: a critical review of current data.

• Authors : McMullin, Mary F.; Wilkins, Bridget S.; Harrison, Claire N.

Subjects: POLYCYTHEMIA treatment; HYDROXYUREA; STAT proteins

• Source: British Journal of Haematology; Feb2016, Vol. 172 Issue 3, p337-349, 13p

Record details

Differential constitutive activation between STAT-related proteins and MAP kinase in primary acute myelogenous leukaemia.

• Authors : Hayakawa, Fumihiko; Towatari, Masayuki; Iida, Hiroatsu

Subjects: PROTEIN kinases; ACUTE myeloid leukemia

• Source: British Journal of Haematology; Jun98, Vol. 101 Issue 3, p521-528, 8p, 4 Diagrams, 3 Charts

Record details

Combined IL-6 and JAK/STAT inhibition therapy in COVID-19-related sHLH, potential game changer.

• Authors : Portsmore S; Royal Berkshire Hospital NHS Foundation Trust, Reading, UK.; Tran Nguyen TN

Subjects: COVID-19*/COVID-19*/COVID-19*/blood ; COVID-19*/COVID-19*/COVID-19*/complications ; COVID-19*/COVID-19*/COVID-19*/diagnostic imaging

• Source: British journal of haematology [Br J Haematol] 2020 Aug; Vol. 190 (4), pp. 525-528. Date of Electronic Publication: 2020 Jul 22.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Mutations in the JAK/STAT pathway genes and activation of the pathway, a relevant finding in nodal Peripheral T-cell lymphoma.

• Authors : Manso R; Pathology Department, Fundación Jiménez Díaz, UAM, Madrid, Spain.; Sánchez-Beato M

Subjects: Janus Kinases*/Janus Kinases*/Janus Kinases*/genetics ; Janus Kinases*/Janus Kinases*/Janus Kinases*/metabolism ; Lymphoma, T-Cell, Peripheral*/Lymphoma, T-Cell, Peripheral*/Lymphoma, T-Cell, Peripheral*/genetics

• Source: British journal of haematology [Br J Haematol] 2018 Nov; Vol. 183 (3), pp. 497-501. Date of Electronic Publication: 2017 Oct 26.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Stimulation of invariant natural killer T cells by α-Galactosylceramide activates the JAK-STAT pathway in endothelial cells and reduces angiogenesis in the 5T33 multiple myeloma model.

• Authors : Nur H; Department of Haematology and Immunology, Myeloma Centre Brussels, Vrije Universiteit Brussel (VUB), Brussels, Belgium; Department of Biology, Faculty of Science and Technology, Hebron University, Hebron, Palestine.

Subjects: Galactosylceramides/Galactosylceramides/Galactosylceramides/*pharmacology ; Janus Kinases/Janus Kinases/Janus Kinases/*immunology ; Multiple Myeloma/Multiple Myeloma/Multiple Myeloma/*immunology

• Source: British journal of haematology [Br J Haematol] 2014 Dec; Vol. 167 (5), pp. 651-63. Date of Electronic Publication: 2014 Aug 21.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details